1. Home
  2. RNW vs SUPN Comparison

RNW vs SUPN Comparison

Compare RNW & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RNW
  • SUPN
  • Stock Information
  • Founded
  • RNW 2011
  • SUPN 2005
  • Country
  • RNW United Kingdom
  • SUPN United States
  • Employees
  • RNW N/A
  • SUPN N/A
  • Industry
  • RNW Electric Utilities: Central
  • SUPN Biotechnology: Pharmaceutical Preparations
  • Sector
  • RNW Utilities
  • SUPN Health Care
  • Exchange
  • RNW Nasdaq
  • SUPN Nasdaq
  • Market Cap
  • RNW 2.5B
  • SUPN 2.1B
  • IPO Year
  • RNW N/A
  • SUPN 2012
  • Fundamental
  • Price
  • RNW $6.78
  • SUPN $37.74
  • Analyst Decision
  • RNW Strong Buy
  • SUPN Hold
  • Analyst Count
  • RNW 1
  • SUPN 1
  • Target Price
  • RNW $8.00
  • SUPN $36.00
  • AVG Volume (30 Days)
  • RNW 1.3M
  • SUPN 376.5K
  • Earning Date
  • RNW 02-18-2025
  • SUPN 02-25-2025
  • Dividend Yield
  • RNW N/A
  • SUPN N/A
  • EPS Growth
  • RNW N/A
  • SUPN 130.79
  • EPS
  • RNW 0.05
  • SUPN 1.07
  • Revenue
  • RNW $998,525,966.00
  • SUPN $651,972,000.00
  • Revenue This Year
  • RNW N/A
  • SUPN $7.82
  • Revenue Next Year
  • RNW $30.03
  • SUPN N/A
  • P/E Ratio
  • RNW $125.57
  • SUPN $35.28
  • Revenue Growth
  • RNW N/A
  • SUPN 6.79
  • 52 Week Low
  • RNW $5.15
  • SUPN $25.53
  • 52 Week High
  • RNW $7.49
  • SUPN $39.37
  • Technical
  • Relative Strength Index (RSI)
  • RNW 53.97
  • SUPN 57.78
  • Support Level
  • RNW $6.45
  • SUPN $36.48
  • Resistance Level
  • RNW $7.09
  • SUPN $38.68
  • Average True Range (ATR)
  • RNW 0.19
  • SUPN 1.06
  • MACD
  • RNW -0.05
  • SUPN 0.09
  • Stochastic Oscillator
  • RNW 51.56
  • SUPN 68.46

About RNW ReNew Energy Global plc

ReNew Energy Global PLC is a developer and operator of clean energy projects intended to meet India's growing energy needs in an efficient, sustainable and socially responsible manner. The company provides end-to-end solutions in a just and inclusive manner in the areas of clean energy, value-added energy offerings through digitalization, storage, and carbon markets that increasingly are integral to addressing climate change. The company has four reportable segments: wind power and solar power, hydro power and transmission line. It derives maximum revenue from Wind Power segment.

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. The Company's diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.

Share on Social Networks: